We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

215 hedge funds and large institutions have $2.47B invested in Arena Pharmaceuticals Inc in 2019 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 69 increasing their positions, 43 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

152% more first-time investments, than exits

New positions opened: 58 | Existing positions closed: 23

60% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 43

31% more capital invested

Capital invested by funds: $1.88B → $2.47B (+$586M)

19% more call options, than puts

Call options by funds: $19.5M | Put options by funds: $16.4M

17% more funds holding

Funds holding: 184 → 215 (+31)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
215
Holders Change
+31
Holders Change %
+16.85%
% of All Funds
4.67%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
58
Increased
69
Reduced
43
Closed
23
Calls
$19.5M
Puts
$16.4M
Net Calls
+$3.06M
Net Calls Change
-$6.54M

Top Buyers

1
AllianceBernstein
AllianceBernstein
Tennessee
+$50.6M
2
N
Nuveen
North Carolina
+$23.4M
3
EMG
ETF Managers Group
New Jersey
+$20.9M
4
Invesco
Invesco
Georgia
+$11.2M
5
MCM
Matarin Capital Management
New York
+$10.7M

Top Sellers

1
PHS
PFM Health Sciences
California
-$73.7M
2
RCMNY
Rubric Capital Management (New York)
New York
-$38.4M
3
Citadel Advisors
Citadel Advisors
Florida
-$16.7M
4
MWNA
Marshall Wace North America
New York
-$16.5M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$11M
Name Holding Trade Value Shares
Change 		Change in
Stake
EI
101
EAM Investors
California
$1.49M +$1.31M +25,356 New
State Board of Administration of Florida Retirement System
102
State Board of Administration of Florida Retirement System
Florida
$1.48M +$33.6K +650 +3%
UBS Group
103
UBS Group
Switzerland
$1.38M -$63K -1,219 -5%
SO
104
STRS Ohio
Ohio
$1.33M +$1.11M +21,400 +1,646%
MIM
105
MetLife Investment Management
New Jersey
$1.32M – – –
BC
106
Birchview Capital
Vermont
$1.29M – – –
T. Rowe Price Associates
107
T. Rowe Price Associates
Maryland
$1.29M +$6.56K +127 +0.6%
D.E. Shaw & Co
108
D.E. Shaw & Co
New York
$1.22M +$1.07M +20,788 New
MAM
109
Martingale Asset Management
Massachusetts
$1.2M +$233K +4,504 +28%
AAM
110
Advisors Asset Management
Colorado
$1.18M +$113K +2,185 +12%
ProShare Advisors
111
ProShare Advisors
Maryland
$1.16M -$128K -2,475 -11%
TI
112
Trexquant Investment
Connecticut
$1.15M +$1.02M +19,660 New
TRSOTSOK
113
Teachers Retirement System of the State of Kentucky
Kentucky
$1.14M +$36.9K +714 +4%
AG
114
Advisor Group
Arizona
$1.12M +$774K +14,969 +359%
GAM
115
Gotham Asset Management
New York
$1.12M +$988K +19,122 New
DMK
116
David M. Knott
$1.07M -$948K -18,344 -50%
PIM
117
Partner Investment Management
California
$1.06M -$1.16M -22,446 -55%
QIM
118
Quantitative Investment Management
Virginia
$1.05M +$211K +4,076 +30%
KC
119
Kepos Capital
New York
$983K +$867K +16,769 New
IBT
120
International Biotechnology Trust
United Kingdom
$967K – – –
EGM
121
Engineers Gate Manager
New York
$962K +$848K +16,413 New
RJA
122
Raymond James & Associates
Florida
$942K -$70.9K -1,371 -8%
WG
123
Winton Group
United Kingdom
$928K +$565K +10,937 +224%
MLICM
124
Metropolitan Life Insurance Company (MetLife)
New York
$928K – – –
SFM
125
Systematic Financial Management
New Jersey
$917K +$808K +15,635 New
3 4
5
6 7

ARNA Hedge Fund Activity: Q2 2019 in Review

215 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2019, worth a combined $2.47B — up 31% from $1.88B a quarter earlier.

Buyers outnumbered sellers: 58 funds opened new ARNA positions and 23 closed out — a net gain of 35 holders — while 69 added to existing stakes and 43 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $50.6M. The largest seller was PFM Health Sciences, cutting an estimated $73.7M.

  • 215 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2019, up from 184 in Q1 2019.
  • Funds reported $2.47B of Arena Pharmaceuticals Inc stock for Q2 2019, up 31% quarter-over-quarter.
  • 58 funds opened new Arena Pharmaceuticals Inc positions in Q2 2019 and 23 closed out, a net change of +35 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2019 was AllianceBernstein, an estimated $50.6M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2019 was PFM Health Sciences, an estimated $73.7M sold.

Based on aggregated 13F filings for Q2 2019.